Ironwood Pharmaceuticals IRWD is preparing to release its quarterly earnings on Thursday, 2024-11-07. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Ironwood Pharmaceuticals to report an earnings per share (EPS) of $0.08.
Ironwood Pharmaceuticals bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Past Earnings Performance
The company's EPS missed by $0.14 in the last quarter, leading to a 4.69% increase in the share price on the following day.
Here's a look at Ironwood Pharmaceuticals's past performance and the resulting price change:
Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
---|---|---|---|---|
EPS Estimate | 0.15 | 0.20 | 0.21 | 0.16 |
EPS Actual | 0.01 | -0.02 | 0 | 0.12 |
Price Change % | 5.0% | 4.0% | -3.0% | 2.0% |
Ironwood Pharmaceuticals Share Price Analysis
Shares of Ironwood Pharmaceuticals were trading at $4.49 as of November 05. Over the last 52-week period, shares are down 49.05%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.